Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987 - Bellmunt, J; von der Maase, H; Mead, G M (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012)
et al.